Latest Breaking News On - Using imprint - Page 1 : comparemela.com

Data from the ongoing phase 2 trial show that clinicians can use ImPrint, an immune-related biomarker, to identify breast cancer patients who are likely to respond to neoadjuvant immunotherapy.

United-states
San-francisco
California
American
Denisem-wolf
American-association-for-cancer-research
Msc-of-the-university-california
University-of-alabama-at-birmingham
Using-imprint
American-association
Cancer-research